Archive for December, 2009

Over the four-year period, a total of 56 patients were treated, out of which 32 (57.1%) were children <15 years, while the remaining 24 (42.9%) were adults aged >15 years. There were 31 males and 25 females, giving the male-to-female ratio of 1.2:1; the corresponding sex ratios for children and adults were 1.7:1 and 1:1.2, [...]

INTRODUCTION
Preterm delivery remains a major cause of morbidity and mortality in the United States, with African Americans bearing a disproportionate share of this adverse outcome. In 1997, urban mothers of African-American infants, compared with mothers of non-Hispanic white infants were 145% more likely to experience the death of a baby before the infant’s first birthday. [...]

This is a four-year prospective descriptive study of all consecutive patients with NF treated at the Usmanu Danfodiyo University Teaching Hospital, Sokoto, from January 2001 to December 2004. Approval for the study was obtained from the hospital’s ethical committee on research. Permission to include the patients in the study was sought from each patient or [...]

INTRODUCTION
In 1952, Wilson coined the term necrotizing fasciitis (NF) to describe a rapidly progressive inflammation and necrosis of subcutaneous tissue and fascia. Before then, the disease had been described under various nomenclature, such as hemolytic gangrene, acute streptococcal gangrene, gangrenous erysipelas, necrotizing erysipelas, suppurative fasciitis and hospital gangrene, just to mention a few. However, the [...]

Thiazolidinediones
Another area of investigation concerns the role of the thiazolidinediones in CVD prevention. Rosigli­tazone, a peroxisome proliferator-activated receptor (PPAR)-g agonist that is used in the treatment of type-2 diabetes, is also known to have anti-inflammatory effects. In 84 patients with stable, angio-graphically documented CAD and no diabetes who were randomized to rosiglitazone or placebo for [...]

Pages: Prev 1 2 3 4 5 6

top